Drug-Induced Pancreatitis

Werth B, Kuhn MK H, Reinhart WH. Medikamentös induzierte Pankreatiden: Erfahrungen der Schweizerischen Arzneimittel-Nebenwirkungenszentrale (SANZ) 1981–1993. Schweiz Med Wochenschr 1995; 125: 731–4 Steinberg W. Acute pancreatitis. N Engl J Med 1994; 330(17): 1198–210 Corfield AP, Cooper MJ, Williamson RCN. Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985; 26: 724–9 Thomson S, Hendry W, McFarlane G, et al. Epidemiology and outcome of acute pancreatitis. Br J Surg 1987; 74: 398–401 Lankisch PG, Dräge M, Gottesleben F. Drug induced pancreatitis: incidence and severity. Gut 1995; 37: 565–7 Cappell MS, Marks M. Acute pancreatitis in HIV-seropositive patients: a case control study in 44 patients. Am J Med 1995; 98: 243–8 Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA 1975; 234(12): 1236–41 Bireher J. Criteria for the diagnosis of adverse drug reactions. Baillieres Clin Gastroenterol 1988; 2: 259–61 Bouvert E, Casalino E, Prevost M, et al. Fatal case of 2′,3′-dideoxyinosine-associated pancreatitis. Lancet 1990; 336: 1515 Schindzielorz A, Pike I, Daniels M, et al. Rates and risk factors for adverse events associated with didanosine in the expanded access program. Clin Infect Dis 1994; 19(6): 1076–83 Maxson C, Greenfield S, Turner J. Acute pancreatitis as a common complication of 2′3′-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87(6): 708–13 Yarchoan R, Mitsuya H, Pluda J, et al. The national cancer institute phase I study of 2′,3′-dideoxyinosine administration in adults with AIDS-related complex: analysis of activity and toxicity profiles. Rev Infect Dis 1990; 12: S522–S233 Valentine F, Seidlin M, Hockster H, et al. Phase I study of 2′,3′-dideoxyinosine: experience with 19 patients at New York University Medical Center. Rev Infect Dis 1990; 12: S534–S539 Rozencweig M, McLaren C, Beltangady M, et al. Overview of Phase I trials of 2′,3′-dideoxyinosine (ddl) conducted on adult patients. Rev Infect Dis 1990; 12: S570–S575 Dolin R, Lambert J, Morse G, et al. 2′3′-Dideoxyinosine in patients with AIDS or AIDS-related complex. Rev Infect Dis 1990; 12: S540–S551 Butler K, Husson R, Balis F, et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991; 324: 137–144 Cooley T, Knuches L, Saunders C, et al. Treatment of AIDS and AIDS-related complex with 2′,3′-dideoxyinosine given once daily. Rev Infect Dis 1990; 12: S552–S560 Seidlin M, Lambert JS, Dolin R, et al. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS 1992; 6: 831–5 Grasela T, Walawander C, Beltangady M, et al. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis 1994; 169: 1250–5 Butler K, Venzon D, Henry N, et al. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993; 91: 747–51 Lambert J, Seidlin M, Valentine F, et al. Didanosine: long term follow up of patients in a phase I study CID 1993; 16(Suppl. 1): S40–S45 Moyle G, Nelson M, Hawkins D, et al. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT). Q J Med 1993; 86: 155–63 Brivet F, Coffin B, Bedossa P, et al. Pancreatic lesions in AIDS. Lancet 1987; II: 570–1 Clas D, Falutz J, Rosenberg L. Acute pancreatitis associated with HIV infection. Can Med Assoc J 1989; 140: 823 Schwartz M, Brandt L. The spectrum of pancreatic disorders in patients with the Acquired Immune Deficiency Syndrome. Am J Gastroenterol 1989; 84(5): 459–62 Asconape J, Penry J, Dreifuss F, et al. Valproate-associated pancreatitis. Epilepsia 1993; 34: 177–83 Binek J, Hany A, Heer M. Valproic-acid-induced pancreatitis Case report and review of the literature. J Clin Gastroenterol 1991; 13(6): 690–3 Kayemba Kay’s Kabangu S, Bovier Lapierre M, Jalaquier E. Pancreatite aigue et acide valproique. Pediatrie 1991; 46(12): 839–43 Williams L, Emery J. Pancreatitis during sodium valproate treatment. Arch Dis Child 1983; 58: 543–4 Rosenberg H, Ortega W. Hemorrhagic pancreatitis in a young child following valproic acid therapy. Clin Pediatr 1987; 26: 98–101 Wyllie E, Wyllie R, Cruse R, et al. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984; 138: 912–4 Ng J, Disney A, Jones T, et al. Acute pancreatitis and sodium valproate. Med J Aust 1982; 21: 362 Murphy M, Lyon L, Taylor J. Valproic acid associated pancreatitis in an adult. Lancet 1981; I: 41–2 Lott J, Bond L, Bobo R, et al. Valproic acid-associated pancreatitis: Report of three cases and a brief review. Clin Chem 1990; 36: 395–7 Coulter D, Allen R. Pancreatitis associated with valproic acid therapy for epilepsy. Ann Neurol 1980; 7: 92 Camfield P, Bagnell P, Camfield C, et al. Pancreatitis due to valproic acid [letter]. Lancet 1979; I: 1198 Batalden P, Van Dyne B, Cloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics 1979; 64: 520–2 Parker P, Helinek G, Ghishan F, et al. Recurrent pancreatitis induced by valproic acid. Gastroenterology 1981; 80: 826–8 Sasaki M, Tonoda S, Aoki Y, et al. Pancreatitis due to valproic acid [letter]. Lancet 1980; I: 1196 Committee on Safety of Medicines. Drug-induced pancreatitis. In: Rawlings M. Langman M, Wood S, et al, editors. Current Problems in Pharmacovigilance. London: Medicines Control Agency, 1994: 2–3 Walker R, Smith G, Barsoum N, et al. Preclinical toxicology of the anticonvulsant calcium valproate. Toxicology 1990; 63: 137–55 Block M, Genant H, Kirsner J. Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med 1970; 282: 380–2 Faintuch J, Mott C, Machado M. Pancreatitis and pancreatic necrosis during sulfasalazine therapy. Int Surg 1985; 70: 271–2 Suryapranta H, deVries H. Pancreatitis associated with sulfasalazine. BMJ 1986; 292: 732 Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol 1994; 89: 789–91 Abdullah A, Scott R, Martin S. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with Ulcerative Colitis. J Pediatr Gastroenterol Nutr 1993; 17: 441–4 Debongnie J, Dekoninck X. Sulfasalazine, 5-ASA and acute pancreatitis in Crohn’s Disease. J Clin Gastroenterol 1994; 19: 348–9 Delgado Fontaneda E, Garcia Campos F, Ruiz Rebollo L, et al. Pancreatitis aguda por salazopirina — una asociacion excepcional. Rev Esp Enferm Dig 1991; 79: 439–40 Erdkamp F, Houben M, Ackerman E, et al. Pancreatitis induced by mesalazine. Neth J Med 1992; 41: 71–2 Garau P, Orenstein S, Neigut D, et al. Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994; 18: 481–5 Radke M, Bartolomaeus G, Müller M, et al. Acute pancreatitis in Crohn’s disease due to 5-ASA therapy. J Pediatr Gastroenterol Nutr 1993; 16: 337–9 Chiba M, Horie Y, Ishida H, et al. A case of salicylazosulfapyridine induced acute pancreatitis with positive lymphocyte stimulation test. Gastroenterol Jpn 1987; 22: 228–33 Brazer S, Medoff J. Sulfonamide-induced pancreatitis Pancreas 1988; 5: 583–6 Van Arsdel PJ. Adverse drug reactions. St Louis: The C.V. Mosby Co, 1983: 1389–414 Poldermans D, Van Blankenstein M. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol 1988; 83: 578–80 Howard J. Pancreatitis: multiple diseases with multiple causes and varying natural histories. In: Howard J, Jordan G, Reber H, editors. Surgical diseases of the pancreas. Philadelphia: Lea&Febiger, 1987: 204–7 Eisner T, Goldman I, Mc Kinley M. Crohn’s disease and pancreatitis. Am J Gastroenterol 1993; 88: 583–6 Weber P, Seibold F, Jenss H. Acute pancreatitis in Crohn’s disease. J Clin Gastroenterol 1993; 17(4): 286–91 Bank S, Marks I. Hyperlipemic pancreatitis and the pill. Postgrad Med J 1970; 46: 576–88 Glueck C, Scheel D, Fishback J, et al. Estrogen induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism 1972; 21: 657–66 Mungall I, Hague R. Pancreatitis and the pill. Postgrad Med J 1975; 51: 855–7 Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med 1973; 289: 552–5 Foster M, Powell D. Pancreatitis, multiple infarcts and oral contraception. Postgrad Med J 1975; 51: 667–9 Parker W. Estrogen-induced pancreatitis (clinical conference). Clin Pharm 1983; 2: 75–9 Schaefer J, Steinmetz A, Dugi K, et al. Durch orale Kontrazeptiva induzierte Pankreatitis bei Hyperchylomikronamie-Syndrom. Deutsch Med Wochenschr 1995; 120: 325–8 Glueck C, Lang J, Hamer T, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994; 123: 59–64 Zorilla E, Hulse M, Hernandez A, et al. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives. J Clin Endocrinol 1968; 28: 1793–6 Frick T, Fryd D, Sutherland D, et al. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients: data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987; 154: 487–9 Mixter CJ, Keynes M, Cope O. Further experience with pancreatitis as a diagnostic clue to hyperparathyroidism. N Engl J Med 1962; 266: 265–72 Payne J, Tanenberg R. Hyperparathyroid crisis and acute necrotizing pancreatitis presenting as diabetic ketoacidosis. Am J Surg 1980; 140: 698–703 Gafter U, Mandel EM, Har Zahav L, et al. Acute pancreatitis secondary to hypercalcemia: occurrence in a patient with breast carcinoma. JAMA 1976; 235: 2004–5 May P, Levy R. Thyrotoxicosis associated with renal tubular necrosis and acute pancreatitis: a case report. Ann Intern Med 1976; 84: 569–70 Davies M, Kliniuk P, Adams P, et al. Familial hypocalciuric hypercalcemia and acute pancreatitis. BMJ 1981; 282: 1023–5 Meltzer L, Palmon F, Paik Y, et al. Acute pancreatitis secondary to hypercalcemia of multiple myeloma. Ann Intern Med 1962; 57: 1008–12 Fernández-del Castillo C, Harringer W, Warshaw A, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382–7 Hochgelerent E, David D. Acute pancreatitis secondary to calcium infusion in a dialysis patient. Arch Surg 1974; 108: 218–9 Izsak E, Shilke M, Roulet M, et al. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition. Gastroenterology 1980; 79: 555–8 Manson R. Acute pancreatitis secondary to iatrogenic hypercalcemia: implications of hyperalimentation. Arch Surg 1974; 108: 213–5 Evans D, Slapak M. Pancreatitis in the hard water syndrome. BMJ 1975; 3: 748 DeWaele B, Smith J, Willems G. Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning. Pancreas 1989; 4: 378–80 Leeson P, Fourman P. Acute pancreatitis from vitamin-D poisoning in a patient with parathyroid deficiency Lancet 1966; I: 1185–6 Cates M, Singh S, Peick A, et al. Acute hypercalcemia, pancreatic duct permeability, and pancreatitis in cats. Surgery 1988; 104: 137–41 Frick T, Hailemariam S, Heitz P, et al. Acute hypercalcemia induces acinar cell necrosis and intraductal precipitates in the pancreas of cat and guinea pig. Gastroenterology 1990; 98: 1675–81 Kelly T. Relationship of hyperparathyroidism and pancreatitis. Arch Surg 1968; 97: 267–74 Schmidt H, Creutzfeld T. Calciphylactic pancreatitis and pancreatitis in hyperparathyroidism. Clin Orthop 1970; 69: 135–45 Renner I, Savage W, Pantoja J, et al. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30: 1005–18 Bleyl U. Die sogenannte nervale Pankreatitis und ihre pathophysiologischen Grundlagen. Z Gastroenterol 1963; 1: 335–50 Dressel T, Goodale Jr R, Arneson M, et al. Pancreatitis as a complication of anticholinesterase insecticide intoxication. Ann Surg 1979; 189: 199–204 Dagli A, Shaikh W. Pancreatic involvement in malathion-anti-cholinesterase insecticide intoxication: a study of 75 cases. Br J Clin Pract 1983; 37: 270–2 Lankisch P, Müller C, Niederstadt H, et al. Painless acute pancreatitis subsequent to anticholinesterase insecticide (parathion) intoxication. Am J Gastroenterol 1990; 85: 872–5 Marsh W, Vukov G, Conradi E. Acute pancreatitis after cutaneous exposure to an organophosphate insecticide. Am J Gastroenterol 1988; 83: 1158–60 Moore P, James O. Acute pancreatitis induced by acute organophosphate poisoning? Postgrad Med J 1981; 57: 660–2 Moritz F, Droy J, Dutheil G, et al. Acute pancreatitis after carbamate insecticide intoxication. Intensive Care Med 1994; 20: 49–50 Weizman Z, Sofer S. Acute pancreatitis in children with anticholinesterase insecticide intoxication. Pediatrics 1992; 90: 204–6 Dressel T, Goodale Jr R, Zweber B, et al. The effect of atropine and duct decompression on the evolution of diazinon-induced acute canine pancreatitis. Ann Surg 1982; 195: 424–34 Frick T, Dalo S, O’Leary J, et al. Effects of insecticide, diazinon, on pancreas of dog, cat and guinea pig. J Environ Pathol Toxicol Oncol 1987; 7: 1–11 Laguna F, Soriano V, González-Labor J. Misdiagnosis in patients receiving treatment with pentavalent antimonal patients. Clin Infect Dis 1994; 19: 978–9 McCarthy A, Keystone J, Kain K. Pancreatitis occurring during therapy with stibogluconate: two case reports. Clin Infect Dis 1993; 17: 952–3 Halim M, Alfurayh O, Kalin M, et al. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin Infect Dis 1993; 16: 397–9 de Lalla F, Pellizer G, Gradoni L, et al. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral Leishmaniasis. Clin Infect Dis 1993; 16: 730–1 Donovan K, White A, Cooke D, et al. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant patient. J Infect 1990; 21: 107–10 Eckhauser M, Dokler M, Imbembo A. Diuretic-associated pancreatitis: a collective review and illustrative cases. Am J Gastroenterol 1987; 82: 865–70 Prigogine T, Futeral B, Kraytman M. Acute hemorrhagic pancreatitis associated with chlorthalidone therapy. Acta Clin Belg 1978; 33: 272 McCormick P, Malone D, Fitzgerald M, et al. Pancreatitis in sarcoidosis. BMJ 1985; 290: 1472–3 Pickleman J, Straus F, Paloyan E. Pancreatitis associated with thiazide administration. Arch Surg 1979; 114: 1013–6 Wenger J, Gross P. Acute hemorrhagic pancreatitis related to hydrochlorothiazide therapy. Gastroenterology 1964; 46: 768 Johnston D, Cornish A. Acute pancreatitis in patients receiving chlorothiazide. JAMA 1959; 170: 2054–6 Diamond M. Hyperglycemic hyperosmolar coma associated with hydrochlorothiazide and pancreatitis. NY State J Med 1972; 72: 1741–2 Ances I, McClain C. Acute pancreatitis following the use of thiazide in pregnancy. South Med J 1971; 64: 267–9 Jones M, Caldwell J. Acute hemorrhagic pancreatitis associated with administration of chlorthialidone. N Engl J Med 1962; 267: 1029–30 Minkowitz S, Soloway H, Hall J, et al. Fatal hemorrhagic pancreatitis following chlorothiazide administration in pregnancy. Obstet Gynecol 1964; 24: 337–42 Rion J. Recurrent pancreatitis after treatment with hydrochlorthiazide. J Am Board Fam Pract 1994; 7: 74–6 Fuchs J, Keith M, Galanos A. Probable metolazone-induced pancreatitis. DICP 1989; 23: 711 Andersson P, Ellis G, Austin S. Metolazone-associated hypercalcemia and acute pancreatitis. Am J Med Sci 1991; 302: 235–7 Mussche M, DeBroe M, Belpaire F, et al. Oral diazoxide contraindicated in severe hypertension with renal failure. Clin Nephrol 1975; 4: 99–103 Cornish A, McClellan J, Johnston D. Effects of chlorothiazide on the pancreas. N Engl J Med 1961; 265: 673–5 Edwards B, Baer P, Sutton R, et al. Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron. J Clin Invest 1973; 52: 2418–27 Pauwels A, Eliaszewicz M, Larrey D, et al. Pentamidine-induced pancreatitis in a patient with AIDS. J Clin Gastroenterol 1990; 12: 457–9 Herer B, Chient T, Labrune S, et al. Pentamidine associated with pentamidine by aerosol. BMJ 1989; 298: 605 Kumar S, Schnadig V, MacGregor M. Fatal acute pancreatitis associated with pentamidine therapy. Am J Gastroenterol 1989; 84: 451–3 Salmeron S, Petitpretz P, Katlama C, et al. Pentamidine and pancreatitis. Ann Intern Med 1986; 105: 140–1 Hart C. Aerosolized pentamidine and pancreatitis. Ann Intern Med 1989; 111: 691 Schwartz M, Cappell M. Pentamidine-associated pancreatitis. Dig Dis Sci 1989; 34: 1617–20 Zuger A, Wolf B, El-Sadr W, et al. Pentamidine-associated fatal acute pancreatitis. JAMA 1986; 256: 2383–5 Foisy M, Slayter K, Hewitt R, et al. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. Ann Pharmacother 1994; 28: 1025–8 Klatt E. Pathology of Pentamidine-induced pancreatitis. Arch Pathol Lab Med 1992; 116: 162–4 Sauleda J, Gea J, Aguar M, et al. Probable pentamidine-induced pancreatitis. Ann Pharmacother 1994; 28: 52–3 Pais J, Cazorla C, Novo E, et al. Massive haemorrhage from rupture of a pancreatic pseudocyst after pentamidine associated pancreatitis. Eur J Med 1992; 1: 251–3 Singh G, El-Gadi S, Sparks R. Pancreatitis associated with aerosolised pentamidine. Genitourin Med 1995; 71: 130–1 Murphey S, Josephs A. Acute pancreatitis associated with pentamidine therapy. Arch Intern Med 1981; 141: 56–8 Buchard P, Sai P, Reach G. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 1982; 31: 40–5 Boillot D, Veld P, Sai P. Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro. Diabetologia 1985; 28: 359–64 Waalkes T, Denham C, De Vita V. Pentamidine: clinical pharmacologic correlations in man and mice. Clin Pharmacol Ther 1970; 11: 505–12 Roush M, McNutt R, Gray T. The adverse effect dilemma: quest for accessible information. Ann Intern Med 1993; 114: 298–9 Tilkemeier P, Thompson P. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988; 318: 1275–6 Pedro-Botet J, Miralles R, Coll J, et al. Captopril versus enalapril: cough versus pancreatitis. DICP Ann Pharmacother 1990; 24: 438–9 Dabaghi S. ACE inhibitors and pancreatitis. Ann Intern Med 1991; 115: 330–1 Maliekal J, Drake C. Acute pancreatitis associated with the use of lisinopril. Ann Pharmacother 1993; 27: 1465–6 Standridge J. Fulminant pancreatitis associated with lisinopril therapy. South Med J 1994; 87: 179–81 Australian Adverse Drug Reaction Advisory Committee. Pancreatitis and ACE inhibitors [abstract]. Australian Adverse Drug Reactions Bulletin Aug 1989 Pratt C, Simone J, Zee P, et al. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. J Pediatr 1970; 77: 474–83 Tan C, Chang S, Wee K. Acute hemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukemia — a case report. Singapore Med J 1974; 15: 278–82 Shaw M, Barnes C, Madden F, et al. L-asparaginase and pancreatitis. Lancet 1970; II: 721 McLean R, Martin S, Lam-Po-Tang P. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982; II: 1401–2 Jain R, Ramanan S. Iatrogenic pancreatitis. A fatal complication in the induction therapy for acute lymphocytic leukemia. Arch Intern Med 1978; 138: 1726 Greenstein R, Nogeire C, Ohnuma T, et al. Management of aspariginase induced hemorrhagic pancreatitis complicated by pseudocyst. Cancer 1979; 43: 718–22 Halskell C, Canellos G, Leventhal B, et al. L-asparaginase — therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med 1969; 281: 1028–34 Oettgen H, Stephenson P, Schwartz M, et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970; 25: 253–78 Zubrod C. The clinical toxicities of L-asparaginase. Pediatrics 1970; 45: 555–8 Whitecar J, Bodey G, Harris J, et al. Current concepts: L-asparaginase. N Engl J Med 1970; 282: 732–4 Loeb E, Hill J, Hill N, et al. Treatment of acute leukemia with L-asparaginase: recent results. Cancer Res 1970; 33: 204–18 Land V, Sutow W, Fernbach D, et al. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972; 30: 339–47 Jaffe N, Traggis D, Das L, et al. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia. Pediatrics 1972; 49: 590–5 Weetman R, Baehner R. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974; 34: 780–5 Samuels B, Culbert S, Okamura J, et al. Early detection of chemotherapy-related pancreatic enlargement in children using abdominal sonography: a preliminary report. Cancer 1976; 38: 1515–23 Nguyen D, Wilson D, Engelman E, et al. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. South Med J 1987; 80: 1133–6 Schein P, Rakieten N, Gordon M, et al. The toxicity of Escher-ichia coli L-asparaginase. Cancer Res 1969; 29: 426–34 Socinski M, Garwick M. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Ann Intern Med 1988; 108: 567–8 Puckett J, Butler W, McFarland J. Pancreatitis and cancer chemotherapy. Ann Intern Med 1982; 97: 453 Newman C, Ellis D. Pancreatitis during combination chemotherapy. Clin Oncol 1979; 5: 83–4 Nevalainen T. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells. Virchows Arch B Cell Pathol 1975; 18: 119–27 Lerche A, Vyberg M, Kirkegaard E. Acute cholangitis and pancreatitis associated with sulindac. Histopathology 1987; 11: 647–53 Zygmunt D, Williams H, Bienz S. Acute pancreatitis associated with long-term sulindac therapy. West J Med 1986; 144: 461–2 Sugerman H. Sulindac-induced acute pancreatitis mimicking gallstone pancreatitis. Am Surg 1989; 55: 536–8 Goldstein J, Laskin D, Ginsberg G. Sulindac associated with pancreatitis. Ann Intern Med 1980; 93: 115 Lilly E. Pancreatitis after administration of sulindac. JAMA 1981; 246: 2680 Memon A. Pancreatitis and sulindac. Ann Intern Med 1982; 96: 139 Siefkin A. Sulindac and pancreatitis. Ann Intern Med 1980; 93: 932–3 Klein S, Khan M. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy. J Rheumatol 1983; 10: 512–3 Svane S. Acute pancreatitis after treatment with sulindac [Norwegian]. Tidsskr Nor Laegeforen 1992; 112: 1453 Guerra M. Toxicity of indomethacin: report of a case of acute pancreatitis. JAMA 1967; 200: 552–3 Cobb T, Piero J. Acute pancreatitis associated with Ketoprofen. South Med J 1992; 85: 430–1 Khan I, Edward N. Pancreatitis associated with diclofenac. Postgrad Med J 1993; 69: 486–7 Du Ville L, Debeuckelaere S, Reynaert H, et al. Pancreatitis associated with Naproxen. Gastroenterology 1993; 88: 464 Sussmann S. Severe salicylism and acute pancreatitis Calif Med 1963; 99: 29–32 Cabooter M, Elewaut A, Barbier F. Salicylate-induced pancreatitis. Gastroenterology 1981; 80: 214–5 Haye O. Piroxicam and pancreatitis. Ann Intern Med 1986; 104: 895 Van Waalraven A, Edels M, Fong S. Pancreatitis caused by mefenaminic acid. Can Med Assoc J 1982; 126: 894 Bosch J, Valdes M, Oristrell J, et al. Oxyphenbutazone-induced sialadenitis, intrahepatic cholestasis and pancreatitis. Acta Gastroenterol Belg 1985; 48: 529–30 Ruppert G, Barth W. Ibuprofen hypersensitivity in systemic lupus erythematosus. South Med J 1981; 74: 241–2 Caldarola V, Hassett J, Hall A, et al. Hemorrhagic pancreatitis associated with acetaminophen overdose. Am J Gastroenterol 1986; 81: 579–81 Coward R. Paracetamol induced acute pancreatitis. BMJ 1977; 1: 1086 Gilmore I, Tourvas E. Paracetamol-induced acute pancreatitis. BMJ 1977; 1: 753 Mofenson H, Caraccio T, Nawaz H, et al. Acetaminophen induced pancreatitis. J Toxicol Clin Toxicol 1991; 29: 223–30 Olazabal A, Nascimento L. Effect of indomethacin, aspirin and fat-free diet on experimental pancreatitis in the rat. J Lab Clin Med 1980; 96: 570–6 Lankisch P, Koop H, Winkle K, et al. Indomethacin treatment of acute experimental pancreatitis in the rat. Scand J Gastroenterol 1978; 13: 629–33 Jubert P. Clozapine related pancreatitis. Ann Intern Med 1994; 121: 722–3 Martin A. Acute pancreatitis associated with clozapine use. Am J Psychiatry 1992; 149: 714 Frankenburg F, Kando J. Eosinophilia, clozapine and pancreatitis. Lancet 1992; 340: 251 Aziz S, Bergdahl L, Baldwin J, et al. Pancreatitis after cardiac and cardiopulmonary transplantation. Surgery 1985; 97: 653–61 Penn I, Durst A, Machado M, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg 1975; 105: 167–72 Renning J, Warden G, Stevens L, et al. Pancreatitis after renal transplantation. Am J Surg 1972; 123: 293–6 Johnson W, Nabseth D. Pancreatitis in renal transplantation. Ann Surg 1970; 171: 309–14 Corrodi P, Knoblauch M, Binswanger U, et al. Pancreatitis after renal transplantation. Gut 1975; 16: 285–9 Yoshimura N, Nakai I, Ohmori Y, et al. Effect of cyclosporine on endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 11–7 Frick T, Fryd D, Goodale R, et al. Lack of association between azathioprine and acute pancreatitis in renal transplantation patients. Lancet 1991; 337: 251–2 Sturdevant R, Singleton J, Deren J, et al. Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology 1979; 77: 883–6 Huizenga K, Shorter R, Phillips S. Pancreatitis: a specific complication of azathioprine treatment of Crohn’s disease [abstract]. Gastroenterology 1976; 70: 895 Nogueira J, Freedman M. Acute pancreatitis as a complication of imuran therapy in regional enteritis. Gastroenterology 1972; 62: 1040–1 Major G, Moore P. Profound circulatory collapse due to azathioprine. J Royal Soc Med 1985; 78: 1052–3 Kawanishi H, Rudolph E, Bull F. Azathioprine-induced acute pancreatitis. N Engl J Med 1973; 289: 357 Isenberg J. Pancreatitis, amylase clearance, and azathioprine. J Pediatrics 1978; 93: 1043–4 Guillaume P, Grandjean E, Male P. Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis. Dig Dis Sci 1984; 29: 78–80 Paloyan D, Levin B, Simonowitz D. Azathioprine-associated acute pancreatitis. Am J Dig Dis 1977; 22: 839–40 Hamed I, Lindeman R, Czerwinski A. Acute pancreatitis following corticosteroid and azathioprine therapy. Am J Med Sci 1978; 276: 211–9 Broe P, Cameron J. Azathioprine and acute pancreatitis: Studies with an isolated perfused canine pancreas. J Surg Res 1983; 34: 159–63 Dreiling D, Nacchiero M. The effect of imuran on pancreatic secretion. Am J Gastroenterol 1978; 69: 491–3 Kerstein M, Grabman J. Azathioprine as a treatment modality in acute hemorrhagic pancreatitis. Surg Forum 1978; 29: 453 Stenvinkel P, Alvestrand A. Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. Acta Med Scand 1988; 224: 89–91 Buchanan N, Cane R. Frusemide-induced pancreatitis. BMJ 1977; 3: 1417 Call T, Malarkey W, Thomas F. Acute pancreatitis secondary to furosemide with associated hyperlipidemia. Am J Dig Dis 1977; 22: 835–8 Jones P, Oelbaum M. Frusemide-induced pancreatitis. BMJ 1975; i: 133–4 Strunge P. Frusemide-induced pancreatitis [letter]? BMJ 1975; 3: 434 Wilson A, Mehra S, Gomersall C, et al. Acute pancreatitis associated with frusemide therapy. Lancet 1967; I: 105 Thomas F, Sinar D, Caldwell J, et al. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology 1977; 73: 221–5 Schultz J, Adamson J, Workman W, et al. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269: 999–1004 Kunelis C, Peters J, Edmondson H. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965; 38: 359–77 Whalley P, Adams R, Combes B. Tetracycline toxicity in pregnancy. JAMA 1964; 189: 357–62 Peters R, Edmondson H, Mikkelsen W, et al. Tetracycline-induced fatty liver in non-pregnant women. Am J Surg 1967; 113: 622–32 Damjanov I, Arnold R, Faour M. Tetracycline toxicity in a non-pregnant woman. JAMA 1968; 204: 934 Jordan S, Ament M. Pancreatitis in children and adolescents. J Pediatr 1977; 91: 211–6 Nicolau D, Mengedoht D, Kline J. Tetracycline-induced pancreatitis. Am J Gastroenterol 1991; 86: 1669–71 Torosis J, Vender R. Tetracycline-induced pancreatitis. J Clin Gastroenterol 1987; 9: 580–1 Elmore M, Rogge J. Tetracycline-induced pancreatitis Gastroenterology 1981; 81: 1134–6 Celifarco A, Warschauer C, Burakoff R. Metronidazole-induced pancreatitis. Am J Gastroenterol 1989; 84: 958–60 Plotnick B, Cohen I, Tsang T, et al. Metronidazole-induced pancreatitis. Ann Intern Med 1985; 103: 891–2 Sanford K, Mayle J, Dean H, et al. Metronidazole-associated pancreatitis. Ann Intern Med 1988; 109: 756–7 Corey W, Doebbeling B, DeJong K, et al. Metronidazole-induced acute pancreatitis. Rev Infect Dis 1991; 13: 1213–5 Friedman G, Selby J. How often does metronidazole induce pancreatitis? Gastroenterology 1990; 98: 1702–3 Sanford K, Mayle J, Dean H, et al. Excessive drug challenge. Ann Intern Med 1989; 110: 410 Scharer L, Smith J. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969; 71: 1113–20 Goldman A, Braman S. Isoniazid: a review with emphasis on adverse effects. Chest 1972; 62: 71–7 Davidson P, Le H. Drug treatment of tuberculosis. Drugs 1992; 43: 651–73 Chan K, Chan H, Lui S, et al. Recurrent acute pancreatitis induced by isoniazid. Tuber Lung Dis 1994; 75: 383–5 Rabassa A, Trey G, Shukla U, et al. Isoniazid-induced pancreatitis. Ann Intern Med 1994; 121: 433–4 Dickson I. Acute pancreatitis following administration of Iso nicotinic acid hydrazide. Br J Tuberculosis 1956; 50: 277 Perry W, Jenkins M, Stamp T. Lysosomal enzymes and pancreatitis during rifampicin therapy. Lancet 1979; I: 492 Riska N, Mattson K. Adverse reactions during rifampicin treatment. Scand J Respir Dis 1972; 53: 87–96 Mattson K. Side effects of rifampicin. Scand J Respir Dis 1973; 82 Suppl.: 1–52 Poole G, Stradling P, Worlledge S. Potentially serious side effects of high-dose twice-weekly rifampicin. BMJ 1971; 3: 343–7 Brockner J, Boisen E. Fatal multisystem toxicity after co-trimoxazole. Lancet 1978; I: 831 Bartels R, van der Spek J, Oosten H. Acute pancreatitis due to sulfamethoxazole-trirnethoprim. South Med J 1992; 85: 1006–7 Barret P, Thier S. Meningitis and acute pancreatitis associated with sulfamethoxazole. N Engl J Med 1963; 268: 36–7 Antonow D. Acute pancreatitis associated with trimethoprim-sulfamethoxazole. Ann Intern Med 1986; 104: 363–5 Christophe J. Pancreatitis induced by nitrofurantoin. Gut 1993; 35: 712–3 Nelis G. Nitrofurantoin-induced pancreatitis: report of a case. Gastroenterology 1983; 84: 1032–4 Davis T, Keeffe EB. Acute pancreatitis and acute hepatitis A. Am J Gastroenterol 1992; 87: 1648–50 Meylan P, Calandra T, Casey P, et al. Clinical experience with timetin in severe hospital infections. J Antimicrob Chemother 1986; 17 Suppl. C: 127–39 Hanline M. Acute pancreatitis caused by ampicillin. South Med J 1987; 80: 1069 Hawksworth C. Acute pancreatitis associated with infusion of erythromycin lactobionate. BMJ 1989; 298: 190 Gumaste V. Erythromycin-induced pancreatitis. Am J Med 1989; 86: 725 Berger T, Cook W, O’Marcaigh A, et al. Acute pancreatitis in a 12 year old girl after an erythromycin overdose. Pediatrics 1992; 90: 624–6 Steed D, Brown B, Reilly J, et al. General surgical complications in heart and heart-lung transplantation. Surgery 1985; 98: 739–44 Calvo D, Patt Y, Wallace S, et al. Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy. Cancer 1980; 45: 1278–83 Bunin N, Meyer W, Christensen M, et al. Pancreatitis following cisplatin: a case report. Cancer Treat Rep 1985; 69: 236–7 Bank L, Wright J. 6-mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease. Dig Dis Sci 1984; 29: 357–9 Haber C, Meltzer S, Present D, et al. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 1986; 91: 982–6 Present D, Korelitz B, Wisch N, et al. Treatment of Crohn’s disease with 6-mercaptopurine. N Engl J Med 1980; 302: 981–7 Heuser E, Liebermann E, Donnell G, et al. Subcutaneous fat necrosis with acute hemorrhagic pancreatitis. Calif Med 1967; 106: 58–63 Cappell M, Das K. Rapid development of pancreatitis following reuse of 6-mercaptopurine. J Clin Gastroenterol 1989; 11: 679–81 Woolley P, III. Hepatic and pancreatic damage produced by cytotoxic drugs. Cancer Treat Rev 1983; 10: 117–37 Altman A, Dinndorf P, Quinn J. Acute pancreatitis in association with cytosine arabinoside therapy. Cancer 1982; 49: 1384–6 Siemers R, Friedenberg W, Norflee R. High-dose cytosine arabinoside-associated pancreatitis. Cancer 1985; 56: 1940–2 Izraeli S, Adamson P, Blaney S, et al. Acute pancreatitis after ifosfamide therapy. Cancer 1994; 74: 1627–8 Lee S, Nichols J, Park H. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326: 589–93 Békássy A, Wiebe T, Hochbergs P. Erwinase-induced pancreatitis. Lancet 1992; 340: 1552–3 Kaplan M, Dreiling D. Steroids revised. Part II. Was cortisone responsible for the pancreatitis? Am J Gastroenterol 1977; 67: 141–7 Steinberg W, Lewis J. Steroid-induced pancreatitis: does it really exist? Gastroenterology 1981; 81: 799–808 Frick T, Speiser D, Bimmler D, et al. Drug-induced pancreatitis: further criticism. Dig Dis 1993; 11: 113–32 Wilde H. Pancreatitis and phenformin. Ann Intern Med 1972; 77: 324 Coodley E, Derasse J, Carver J. Phenformin and pancreatitis. Ann Intern Med 1973; 78: 307 Chase H, Morgan G. Phenformin-associated pancreatitis. Ann Intern Med 1977; 87: 314–5 Graeber G, Marmor B, Hendel RC, et al. Pancreatitis and severe metabolic abnormalities due to phenformin therapy. Arch Surg 1976; 111: 1014–6 Levitan A. Phenformin and pancreatitis. Ann Intern Med 1973; 78: 306–7 Ryan L, Hankwitz P, Banasiak M. Phenformin and pancreatitis. Ann Intern Med 1977; 87: 796 Wu S, Wolf J. Phenformin and pancreatitis. Ann Intern Med 1978; 88: 128 Sastri SV, Diaz-Arias AA, Marshall JB. Can pancreatitis be associated with amiodarone hepatotoxicity? J Clin Gastroenterol 1990; 12: 70–7 Sebastian Domingo J, Simon Marco M, Uribarrena Echebarria R. Hepatic and pancreatic injury associated with amineptine therapy. J Clin Gastroenterol 1994; 18: 168–9 Branch A. Pancreatic necrosis in ethyl alcohol, methyl alcohol and arsenic poisoning. Can Med Assoc J 1944; 51: 428–30 Durrington PN, Cairns SA. Acute pancreatitis: a complication of beta-blockade. BMJ 1982; 284: 1016 Soman M, Swenson C. A possible cause of carbamazepine-induced pancreatitis. Drug Intell Clin Pharm 1985; 19: 925–6 Tsao C, Wright F. Acute chemical pancreatitis associated with carbamazepine intoxication. Epilepsia 1993; 34: 174–6 Speckmann K. Über Pankreasschädigungen durch Tetrachlorkohlenstoff. Arztl Wochenschr 1953; 8: 1051–2 Moon HD. The pathology of fatal carbon-tetrachloride poisoning with special reference to the histogenesis of the hepatic and renal lesions. Am J Pathol 1950; 26: 1041–57 Keane FBV, Fennell JS, Tomkin GH. Acute pancreatitis, acute gastric dilatation and duodenal ileus following refeeding in anorexia nervosa. Ir J Med Sci 1978; 147: 191–2 Casdorph HR. The efficacy and safety of cholestyramine therapy in hyperlipidemic patients. Ann Intern Med 1971; 74: 818 Committee of Principal Investigators. A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978; 40: 1069–118 Roberge R, Martin T, Hodgman M, et al. Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose. Clin Toxicol 1994; 32: 425–9 Freemann JS, Panebianco PS. Colchicine overdosage: report of a case. J Am Osteopath Assoc 1982; 82: 252–4 Naidus RM, Rodvien R, Mielke H. Colchicine toxicity. Arch Intern Med 1977; 137: 394–6 Chevalier X, Awada H, Baetz A, et al. Danazol induced pancreatitis and hepatitis. Clin Rheumatol 1990; 9: 239–41 McCormick PA, O’Donoghue D, Brennan N. Diphenoxylate and pancreatitis. Lancet 1985; I: 752 Deviere J, Reuse C, Askenasi R. Ischemic pancreatitis and hepatitis secondary to ergotamine poisoning. J Clin Gastroenterol 1987; 9: 350–2 Thys F, Schapira M, Ghilain J, et al. Acute pancreatitis and fenfluramine. Gastroenterol Clin Biol 1994; 18: 385–6 Tchantz P, Favre H. Pancréatite nécrosante par intoxication à l’acide formique et brûlure à l’acide fluorhydrique. Schweiz Rundsch Med Prax 1975; 64: 487–90 Eisemann AD, Becker NJ, Miner PB, et al. Pancreatitis and gold treatment of rheumatoid arthritis. Ann Intern Med 1989; 111: 860–1 Schrogi JJ, Holt P, Hartley RC, et al. ‘Histamine-induced’ pancreatitis. Gastroenterology 1965; 49: 672–5 Calmus Y, Biour M, Bodin F, et al. Hépatites et pancréatite à l’indalpine. Gastroenterol Clin Biol 1985; 9: 266–8 Noseworthy J, Colodny AH, Eraklis AJ. Pancreatitis and intravenous fat: an association in patients with inflammatory bowel disease. J Pediatr Surg 1983; 18: 269–72 Buckspan R, Woltering E, Waterhouse G. Pancreatitis induced by intravenous infusion of a fat emulsion in an alcoholic patient. South Med J 1984; 77: 251–2 Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn’s disease. Gastroenterology 1986; 90: 1039–41 Flynn WJ, Freeman PG, Wickboldt LG. Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. Ann Intern Med 1987; 107: 63 Pluhar W. Ein Fall möglicher Lovastatin-induzierter Pankreatitis bei gleichzeitigem Gilbert-Syndrom. Wien Klin Wochenschr 1989; 101: 551–4 Bourry J, Sainty JM, Roux JJ, et al. Pancréatites aiguès aucours d’intoxications au méprobamate. Nouv Presse Med 1976; 5: 1918 Meyers DH. Pancreatitis, panniculitis and methandienone. Aust NZJ Med 1982; 12: 302–5 Sanford EW, Mitas JA, Swerdlin AHR. Pancreatitis due to methyldopa: case report. Mil Med 1980; 145: 399–400 Rominger JM, Gutierrez JG, Curtis D, et al. Methyldopa-induced pancreatitis. Am J Dig Dis 1978; 23: 756–8 Van der Heide H, Ten Haaft MA, Strieker BMC. Pancreatitis caused by methyldopa. BMJ 1981; 282: 1930–1 Stecyk O, Loludice TA, Demeter S, et al. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985; 14: 597–9 Tan W, Chapnick E, Abter E, et al. Paromycin-associated pancreatitis in HIV-related cryptosporidosis. Ann Pharmacother 1995; 29: 22–4 Bennett IL, Nation TC, Olley JF. Pancreatitis in methyl alcoholic poisoning. J Lab Clin Med 1952; 40: 405–9 Bennett IL, Freeman HC, Mitchell GL, et al. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine 1953; 32: 431–63 Alberti Flor J. Pancreatitis associated with ondansetron. J Natl Cancer Inst 1995; 87: 689–90 Braganza JM, Jolley JE, Lee WR. Occupational chemicals and pancreatitis: a link? Int J Pancreatol 1986; 1: 9–19 Gradon J, Shulman R, Chapnick E, et al. Octreotide induced pancreatitis in a patient with acquired immunodeficiency syndrome. South Med J 1991; 84: 1410–1 Friedenrich A, Sosset C, Bernard J, et al. Acute pancreatitis after short-term octreotide. Lancet 1991; 338: 52 Lambrianides AL, Rosin RD. Acute pancreatitis complicating excessive intake of phenolphthalein. Postgrad Med J 1984; 60: 491–2 Middleton SJ, Jacyna M, McClaren D, et al. Thomas HC. Hemorrhagic pancreatitis — a cause of death in severe potassium permanganate poisoning. Postgrad Med J 1990; 66: 657–8 Falco JM, Thomas FB. Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med 1975; 83: 832–3 Jeffries JJ, Masson J. Pancreatitis following overdose with amoxapine and procyclidine. Can J Psychiatry 1985; 30: 546–7 Larsen RR, Sawyer RB, Sawyer KC, et al. Hemorrhagic pancreatitis complicating anticoagulant therapy. NY State J Med 1962; XX: 2397–9 Satake K, Nakashima Y. Drug-induced pancreatitis Philadelphia: Lea & Febiger, 1987: 322–9 Nakashima Y, Howard J. Drug-induced acute pancreatitis. Surg Gynecol Obstet 1977; 145: 105–9 Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology 1980; 78: 813–20 Mallory A, Kern F. Drug-induced pancreatitis. Baillieres Clin Gastroenterol 1988; 2: 293–307 Steinberg W. Acute drug and toxin induced pancreatitis. Hosp Pract Off Ed 1985; 20: 95–102 Banerjee A, Patel K, Grainger S. Drug-induced acute pancreatitis: a critical review. Med Toxicol Adverse Drug Exper 1989; 4: 186–98